Search Results - "Ding, Pei-Rong"

This result is not displayed to guests.
Login for full access.

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

Authors: An, Xin Ding, Pei-Rong Li, Yu-Hong et al.

Source: Biomarkers. Sep2010, Vol. 15 Issue 6, p516-522. 7p. 2 Charts, 4 Graphs.

Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy.

Authors: An, Xin Ding, Pei-Rong Xiang, Xiao-Juan et al.

Source: Biomarkers. May2010, Vol. 15 Issue 3, p243-248. 6p. 3 Charts.

Single‐Cell RNA Editing Identifies T Cell ADAR1 as a Key Regulator of Immune Exhaustion and Anti‐PD‐1 Resistance in Colorectal Cancer.

Authors: Kang, Da Xie, Song‐Zuo Luo, Yong‐Zhou et al.

Source: Advanced Science. Jun2026, p1. 19p. 8 Illustrations.

Depth of tumor invasion independently predicts lymph node metastasis in T2 rectal cancer.

Authors: Ding, Pei-Rong An, Xin Cao, Yun et al.

Source: Journal of Gastrointestinal Surgery. Jan2011, Vol. 15 Issue 1, p130-136. 7p.

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

Authors: Wang, De-Shen Ren, Chao Li, Shan-Shan et al.

Source: PLoS Medicine. 5/10/2024, Vol. 21 Issue 5, p1-18. 18p.

The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study.

Authors: Liao, Leen Tang, Jinghua Hong, Zhigang et al.

Source: BMC Cancer. 2/2/2024, Vol. 24 Issue 1, p1-9. 9p.

High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer.

Authors: Wang, Qiao-Xuan Zhang, Shu Xiao, Wei-Wei et al.

Source: Radiation Oncology. 5/18/2022, Vol. 17 Issue 1, p1-10. 10p.

A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study.

Authors: Cao, Lian-Jing Peng, Xiao-Lin Xue, Wen-Qiong et al.

Source: BMC Medicine. 10/25/2021, Vol. 19 Issue 1, p1-15. 15p.

Percutaneous hepatic artery infusion chemotherapy with oxaliplatin and fluoropyrimidines in treatment-resistant colorectal cancer patients with unresectable liver metastases: a retrospective cohort study.

Authors: Pat Fong, William Li, Zi-Jing Ren, Chao et al.

Source: HPB (1365-182X). Mar2025, Vol. 27 Issue 3, p289-298. 10p.

Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome.

Authors: Niu, Shao-Qing Li, Rong-Zhen Yuan, Yan et al.

Source: Radiation Oncology. 5/24/2021, Vol. 16 Issue 1, p1-9. 9p.

The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy.

Authors: Wang, Qiao-xuan Zhang, Rong Xiao, Wei-wei et al.

Source: Radiation Oncology. 1/19/2021, Vol. 16 Issue 1, p1-8. 8p.

The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers.

Authors: Wang, Qiao-Xuan Qu, Chun-Hua Gao, Yuan-Hong et al.

Source: Experimental Hematology & Oncology. 1/4/2021, Vol. 10 Issue 1, p1-4. 4p.

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer.

Authors: Wang, De‐shen Wang, Zhi‐qiang Chen, Gong et al.

Source: Cancer Medicine. Jan2020, Vol. 9 Issue 1, p151-159. 9p.

Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study.

Authors: Yu, Jie-Hai Xiao, Bin-Yi Li, Dan-Dan et al.

Source: Lancet Oncology. Jul2024, Vol. 25 Issue 7, p843-852. 10p.

Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study.

Authors: Sui, Qiaoqi Zheng, Jian Liu, Dingxin et al.

Source: BMC Cancer. 12/12/2019, Vol. 19 Issue 1, p1-10. 10p. 2 Charts, 4 Graphs.

POSTN+ cancer-associated fibroblasts forming fortress-like barrier to mediate immunotherapy resistance in colorectal cancer.

Authors: Zhou, You Yu, Jie-Hai Sui, Qiao-Qi et al.

Source: Cancer Letters. Oct2026, Vol. 657, pN.PAG-N.PAG. 1p.

A frameshift mutation in exon 19 of MLH1 in a Chinese Lynch syndrome family: a pedigree study.

Alternate Title: 一个中国Lynch 综合征家系携带的MLH1 基因 第19 号外显子移码突变:一项家系研究.

Authors: Sui, Qiao-qi Jiang, Wu Wu, Xiao-dan et al.

Source: Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology). Jan2019, Vol. 20 Issue 1, p105-108. 4p.

Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0.

Authors: You, Kai-yun Huang, Rong Ding, Pei-rong et al.

Source: International Journal of Colorectal Disease. Apr2014, Vol. 29 Issue 4, p529-538. 10p.

Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy.

Authors: An, Xin Wang, Feng-Hua Ding, Pei-Rong et al.

Source: Cancer (0008543X). Aug2011, Vol. 117 Issue 16, p3750-3757. 8p.